02315.HK
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
HKSE · Healthcare · Biotechnology · CN
HKD 60.60
−5.53%Next report
Analyst consensus
- Next report date
- Mar 31, 2027
- EPS estimate
- —
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 27, 2026
- EPS actual
- HKD 0.62
- EPS estimate
- —
- Revenue actual
- HKD 1.1B
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- —
- EPS misses (12Q)
- —
- EPS in line (12Q)
- —
- Avg surprise (4Q)
- —
- Revenue beats (12Q)
- —
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Mar 31, 2027